Search
for
Sort by
Research 961–990 of 1000+
- Cerebral Ischemia Related to Isotretinoin; Venlafaxine-Induced Alopecia; Cognitive Dysfunction with Tolterodine; Retinal Artery Occlusion after Injection of Long-Acting Risperidone; Olanzapine-Induced Chylomicronemia Presenting as Pancreatitis; Metabolic Effects of the Atypical Antipsychotics – an Editorial; Another Drug-Induced Pancreatitis – This One Caused by a Tyrosine Kinase Inhibitor; Suicide Attempts Related to Antidepressant Medications
- In vitro study of the antioxidant, sun factor protection, antimicrobial, and antifungal activities with molecular docking of methanolic extracts from leaves and fruit of Phillyrea angustifolia L.
- The iron content of human hair. II. Individuals with disturbed iron metabolism.
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
- Polycystic ovary syndrome
- Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
- Is dehydroepiandrosterone a hormone?
- Complications of Cushing's syndrome: state of the art
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Polycystic ovary syndrome
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Vitamin D: More Than a “Bone-a-Fide” Hormone
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Abdominal Fat Quantity and Distribution in Women with Polycystic Ovary Syndrome and Extent of Its Relation to Insulin Resistance
- The diagnosis of polycystic ovary syndrome in adolescents
- Dermatoses of pregnancy
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
- Testosterone therapy for transgender men
- Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
- Transdermal Permeation of Drugs in Various Animal Species
- Hormone therapy for transgender patients
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- The Circadian Clock in Skin
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin